About Bachem Holding AG

Company Description

Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.

Year founded

1971

Served area

Worldwide

Headquarters

Hauptstrasse 144, 4416 Bubendorf – Switzerland

Shareholder information

Shares outstanding

73,750,000

IPO

May 5, 2022

Stock exchange(s)

SIX Swiss Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.